Larimar Therapeutics, Inc. (LRMR)

Larimar Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	92.69	85.41	33.22	26.75	26.83	70.1
Short-Term Investments	63.58	51.44	150.24	60.04	91.6	-
Cash & Short-Term Investments	156.27	136.85	183.45	86.79	118.43	70.1
Cash Growth	12.81%	-25.40%	111.38%	-26.71%	68.95%	-24.33%
Other Receivables	0.27	0.75	1.05	0.33	-	0.21
Receivables	0.27	0.75	1.05	0.33	-	0.21
Prepaid Expenses	4.14	4.42	10.8	3.05	2.31	1.9
Total Current Assets	160.67	142.02	195.3	90.18	120.74	72.2
Property, Plant & Equipment	3.69	2.69	3.72	3.76	3.69	4.46
Other Long-Term Assets	0.94	1.13	1.2	2	1.98	2.01
Total Assets	165.3	145.84	200.23	95.94	126.41	78.67

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	7.6	5.22	2.42	1.28	1.69	1.66
Accrued Expenses	25.37	58.47	20.87	7.39	8.41	6.59
Current Portion of Leases	1.2	1.11	1.06	0.84	0.61	0.59
Total Current Liabilities	34.17	64.8	24.36	9.51	10.71	8.85
Long-Term Leases	3.75	2.96	4.06	4.71	4.8	5.41
Total Liabilities	37.92	67.76	28.41	14.22	15.5	14.25

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.1	0.08	0.06	0.04	0.04	0.02
Additional Paid-In Capital	624.52	512.78	440.76	270.15	262.5	180.65
Retained Earnings	-497.23	-434.83	-269.16	-188.55	-151.61	-116.25
Comprehensive Income & Other	-0.01	0.05	0.15	0.08	-0.03	-
Shareholders' Equity	127.38	78.09	171.81	81.72	110.9	64.41
Total Liabilities & Equity	165.3	145.84	200.23	95.94	126.41	78.67

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	4.96	4.07	5.12	5.55	5.41	6
Net Cash (Debt)	151.31	132.79	178.34	81.24	113.02	64.1
Net Cash Growth	13.00%	-25.54%	119.51%	-28.12%	76.33%	-25.58%
Net Cash Per Share	1.69	1.82	2.91	1.85	4.39	3.73
Filing Date Shares Outstanding	104.38	104.38	64.03	63.8	43.27	17.71
Total Common Shares Outstanding	104.38	83.34	63.82	43.91	43.27	17.71
Working Capital	126.51	77.23	170.95	80.67	110.03	63.36
Book Value Per Share	1.22	0.94	2.69	1.86	2.56	3.64
Tangible Book Value	127.38	78.09	171.81	81.72	110.9	64.41
Tangible Book Value Per Share	1.22	0.94	2.69	1.86	2.56	3.64
Machinery	2.57	2.42	2.38	1.86	1.71	1.61
Leasehold Improvements	0.09	0.09	0.05	0.05	0.03	0.03

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 4, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 15, 2026

Data Sources Report a data error